These SEL1L-HRD1 variants independently disrupted ERAD function and were associated with a spectrum of phenotypes that the investigators term ERAD-associated neurodevelopmental disorder with onset in infancy (ENDI) syndrome. The gene discussed is SEL1L; the disease is neurodevelopmental disorder.